U.S. Senate Bill Targets Chinese Medical Devices, Putting Cybersecurity Compliance Under the Spotlight

Proposed legislation could require cybersecurity reviews and recalls of Chinese made medical devices, signalling a broader shift in how regulators view supply chain risk.

A bill before the U.S. Senate could significantly reshape cybersecurity compliance for healthcare providers, medical device manufacturers and suppliers by requiring federal authorities to review connected medical devices manufactured in China for potential cyber vulnerabilities. The proposal would also empower regulators to recall devices found to pose unacceptable security risks.

The proposed Countering Chinese Cyberthreats for Patients Act, introduced by Senator Tom Cotton, would direct the U.S. Food and Drug Administration, working with the Cybersecurity and Infrastructure Security Agency, to conduct retrospective cybersecurity reviews of Chinese made, internet connected medical devices already deployed across the U.S. healthcare system. Devices found to present national security or patient safety risks could be recalled.

The legislation follows growing concern over cybersecurity vulnerabilities in connected healthcare equipment, particularly older devices approved before the FDA introduced mandatory cybersecurity requirements for new medical devices in 2023.

In announcing the legislation, Senator Cotton said, “Communist Chinese made medical devices threaten the privacy and safety of every American patient.”

Compliance Analysis

For compliance professionals, the proposed legislation reflects a broader regulatory shift.

Medical devices are no longer assessed solely on their clinical performance or product safety. Increasingly, regulators are treating cybersecurity as an essential component of patient safety, operational resilience and national security.

Hospitals today rely on thousands of connected devices, including patient monitors, infusion pumps, imaging equipment and diagnostic systems. A compromised device could expose sensitive patient information, disrupt clinical services or provide a gateway into wider hospital networks.

That changes the compliance conversation.

Healthcare organisations have traditionally focused on procurement, maintenance and clinical effectiveness when acquiring medical technology. Going forward, cyber resilience and supply chain assurance are likely to become equally important.

The proposed bill also signals that regulators are looking beyond manufacturers. Hospitals, procurement teams, third party vendors and healthcare technology providers may all face greater scrutiny over the devices they purchase, deploy and maintain.

The Bigger Compliance Lesson

Whether the legislation ultimately becomes law or not, its direction is clear.

Supply chain compliance is expanding beyond financial integrity and product quality to include cybersecurity risk.

For healthcare organisations, that means strengthening vendor due diligence, maintaining accurate inventories of connected devices, conducting cybersecurity assessments before procurement and ensuring legacy equipment remains properly monitored throughout its lifecycle.

The proposal also reinforces an emerging global trend. Governments are increasingly treating cyber resilience as a matter of public safety rather than simply an information technology issue.

For compliance officers, the takeaway is straightforward.

Cybersecurity is no longer confined to the IT department. It has become a governance issue that affects procurement, enterprise risk management, regulatory compliance and patient trust.